Evaluating the potential risks and benefits of infant rotavirus vaccination in England

Vaccine

Volumn 32, Issue 29, 2014, Pages 3604-3610

  Clark, Andy ^a   Jit, Mark ^a,b   Andrews, Nick ^b   Atchison, Christina ^c   Edmunds, W John ^a   Sanderson, Colin ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Intussusception; Risk benefit analysis; Rotavirus; Vaccination

Indexed keywords

ROTAVIRUS VACCINE; LIVE VACCINE; RIX4414 VACCINE;

ARTICLE; AUSTRALIA; CHILD; CHILDHOOD MORTALITY; GASTROENTERITIS; HUMAN; INCIDENCE; INTUSSUSCEPTION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; ROTAVIRUS INFECTION; UNITED KINGDOM; VACCINATION REACTION; VACCINE RELATED INTUSSUSCEPTION; COST BENEFIT ANALYSIS; EPIDEMIOLOGY; INFANT; NEWBORN; PRESCHOOL CHILD; RISK ASSESSMENT; ROTAVIRUS INFECTIONS;

CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; ENGLAND; GASTROENTERITIS; HUMANS; INFANT; INFANT, NEWBORN; INTUSSUSCEPTION; RISK ASSESSMENT; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED;

EID: 84901594479     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.082     Document Type: Article

References (32)

1. Jit M., Pebody R., Chen M., Andrews N., Edmunds W.J. Estimating the number of deaths with rotavirus as a cause in England and Wales. Hum Vaccin 2007, 3(1):23-26.
2. Harris J.P., Jit M., Cooper D., Edmunds W.J. Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease. Vaccine 2007, 25(20):3962-3970.
3. Joint letter from DH, PHE and NHS England (30th April 2013). Important changes to the national immunisation programme in 2013/14: introduction of rotavirus vaccination for babies at 2 and 3 months. Available at: [accessed 07.08.13]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/193055/130429_Rotavirus_tripartite_letter_FINAL.pdf.
4. The infant rotavirus vaccination programme - Q&As for healthcare practitioners 2013, Public Health England, Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/224169/Rotavirus_Q_and_As_for_healthcare_practitioners_v4_26_July_2013.pdf [accessed 7.08.13].
5. Jit M., Edmunds W.J. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. Vaccine 2007, 25(20):3971-3979.
6. Jit M., Mangen M.J., Melliez H., Yazdanpanah Y., Bilcke J., Salo H., Edmunds W.J., et al. An update to the cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe. Vaccine 2010, 28(47):7457-7459.
7. Measuring effectiveness and cost effectiveness: the QALY. National Institute for Health and Care Excellence (NICE). Available at: [accessed 07.08.13], 2013. http://www.nice.org.uk/newsroom/features/measuringeffectivenessandcosteffectivenesstheqaly.jsp.
8. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejador J.C., Cohen R., et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007, 370(9601):1757-1763.
9. Tate J.E., Cortese M.M., Payne D.C., Curns A.T., Yen C., Esposito D.H., et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr. Infect Dis J 2011, 30(Suppl. 1):S56-S60.
10. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O., Okoro C.A., et al. Intussusception among infants given an oral rotavirus vaccine. New Engl J Med 2001, 344(8):564-572.
11. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New Engl J Med 2006, 354(1):11-22.
12. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New Engl J Med 2006, 354(1):23-33.
13. Cortese M. Summary of intussusception risk and benefits of rotavirus vaccination in the United States. Centers for Disease Control and Prevention. ACIP Meeting. June 20, 2013 2013, Available at: http://www.cdc.gov/vaccines/acip/meetings/downloads/slides-jun-2013/06-Rotavirus-Cortese.pdf [accessed 19.08.13].
14. Samad L., Marven S., El Bashir H., Sutcliffe A.G., Cameron S., Lynn R., et al. Prospective surveillance study of the management of intussusception in UK and Irish infants. Br J Surg 2012, 99(3):411-415.
15. Patel M.M., Clark A.D., Sanderson C.F., Tate J., Parashar U.D. Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis. PLoS Med 2012, 9(10):e1001330.
16. Rotavirus vaccines, WHO position paper - January 2013. Weekly epidemiological record - 1st FEBRUARY 2013 2013, vol. 88:49-64. http://www.who.int/wer/2013/wer8805.pdf [accessed 07.08.13].
17. Microsoft Excel 2007, Microsoft Corporation, Redmond, WA, USA.
18. Mid-2012 population estimates: England; estimated resident population by single year of age and sex 2013, Office for National Statistics (Crown Copyright), Available at: http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-england-and-wales/mid-2012/rft---mid-2012-population-estimates-for-england-and-wales.zip [accessed 16.08.13].
19. CarePlus Child Health Data for the 2010 birth cohort in 14 regions of England. Available at: [accessed 30th September 2013]. Extraction/analysis of DTP1, DTP2 and DTP3 coverage by week of age by Julia Stowe [Immunisation and Blood Safety Department, Public Health England], 2013. http://mckesson.co.uk/child-health-0.
20. WHO UNICEF estimates time series for United Kingdom of Great Britain and Northern Ireland. WHO-UNICEF estimates of DTP1 coverage. Data as of 12.07.12. Available at: [accessed 19.08.13], 2012. http://apps.who.int/immunization_monitoring/globalsummary/estimates%3Fc=GBR.
21. Hospital Episode Statistics. Extraction/analysis of Intussuception admissions by week of age by Julia Stowe [Immunisation and Blood Safety Department, Public Health England]. Copyright © 2013, Re-used with the permission of the Health & Social Care Information Centre. All rights reserved.
22. Samad L., Cortina-Borja M., Bashir H.E., Sutcliffe A.G., Marven S., Cameron S., et al. Intussusception incidence among infants in the UK and Republic of Ireland: a pre-rotavirus vaccine prospective surveillance study. Vaccine 2013, 31(38):4098-4102.
23. Carlin J.B., Macartney K., Lee K.J., Quinn H.E., Buttery J., Lopert R., et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's national immunisation program. Clin Infect Dis 2013, 57(10):1427-1434.
24. Jiang J., Jiang B., Parashar U., Nguyen T., Bines J., Patel M.M. Childhood intussusception: a literature review. PLoS ONE 2013, 8(7):e68482.
25. Atchison C.J., Lopman B.A., Harris C.J., Tam C.C., Iturriza Gomara M., Gray J.J. Clinical laboratory practices for the detection of rotavirus in England and Wales: can surveillance based on routine laboratory testing data be used to evaluate the impact of vaccination?. Eur Surv: Bulletin Europeen sur les maladies transmissibles=Eur Commun Dis Bull 2009, 14(20):1-6.
26. Atchison C., Lopman B., Edmunds W.J. Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales. Vaccine 2010, 28(18):3118-3126.
27. Yen C., Tate J.E., Steiner C.A., Cortese M.M., Patel M.M., Parashar U.D. Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009. J Infect Dis 2012, 206(1):41-48.
28. Desai R., Cortese M.M., Meltzer M.I., Shankar M., Tate J.E., Yen C., et al. Potential intussusception risk versus benefits of rotavirus vaccination in the United States. Pediatr Infect Dis J 2013, 32(1):1-7.
29. Bauch C.T., Bhattacharyya S. Evolutionary game theory and social learning can determine how vaccine scares unfold. PLoS Comput Biol 2012, 8(4):e1002452.
30. Weijer C. The future of research into rotavirus vaccine. BMJ 2000, 321(7260):525-526.
31. Ibuprofen (c) NHS direct 2013, http://www.nhsdirect.nhs.uk/Headache/~/media/SATFiles/MedsForPain-March2012/IbuprofenFactsheetMarch2012.ashx#page5 [accessed 19.08.13].
32. Sansom S.L., Barker L., Corso P.S., Brown C., Deuson R. Rotavirus vaccine and intussusception: how much risk will parents in the United States accept to obtain vaccine benefits?. Am J Epidemiol 2001, 154(11):1077-1085.